Nicolas Penel

Nicolas Penel

UNVERIFIED PROFILE

Are you Nicolas Penel?   Register this Author

Register author
Nicolas Penel

Nicolas Penel

Publications by authors named "Nicolas Penel"

Are you Nicolas Penel?   Register this Author

100Publications

2615Reads

12Profile Views

Personalised management of alveolar soft part sarcoma: a promising phase 2 study.

Lancet Oncol 2019 Jun 8;20(6):750-752. Epub 2019 May 8.

Department of Medical Oncology and University Claude Bernard, Léon Bérard Cancer Center, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30286-4DOI Listing
June 2019

From rare to well-done: importance of rare tumors in cancer therapeutic advances.

Oncotarget 2019 Jun 18;10(40):3998-3999. Epub 2019 Jun 18.

Oncology Medical Unit, CHU La Timone and Aix-Marseille University, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.27020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592290PMC
June 2019

Tyrosine kinase inhibitors and immune checkpoint inhibitors-induced thyroid disorders.

Crit Rev Oncol Hematol 2019 May 31;141:23-35. Epub 2019 May 31.

Department of Endocrinology and Metabolism, CHU Lille, 59037 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.05.015DOI Listing
May 2019

[Evolution of the regulatory framework in clinical research].

Bull Cancer 2019 Apr 15;106(4):389-394. Epub 2019 Mar 15.

Centre Oscar-Lambret, direction de la recherche clinique et de l'innovation, 3, rue Combemale, 59020 Lille, France; Université Lille-Nord de France, faculté de médecine, place de Verdun, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.01.016DOI Listing
April 2019

[Cancer screening words].

Bull Cancer 2019 Jul - Aug;106(7-8):608-614. Epub 2019 Apr 16.

Université de Lille, faculté de médecine Henri-Warembourg, 2, avenue Eugène-Avinée, 59120 Loos, France; Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551193015
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2019.03.004DOI Listing
April 2019

Non-islet-cell tumour hypoglycaemia (NICTH): About a series of 6 cases.

Ann Endocrinol (Paris) 2019 Feb 16;80(1):21-25. Epub 2018 Mar 16.

Department of endocrinology and metabolism, CHRU Lille, 59037 Lille, France; UMR 1190 translational research in diabetes, Inserm, 59000 Lille, France; EGID (European Genomic Institute for Diabetes), university Lille, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ando.2018.01.005DOI Listing
February 2019

"Impossible" patients in oncology: Two unusual cases.

Palliat Support Care 2019 02 27;17(1):119-121. Epub 2018 Jun 27.

Medical Oncology Department,Centre Oscar Lambret,Lille,59020,France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S147895151800041XDOI Listing
February 2019

[Before seasonal influenza, vaccination of cancer patients and healthcare givers].

Bull Cancer 2019 Feb 30;106(2):94-96. Epub 2019 Jan 30.

Centre Oscar-Lambret, service de soins palliatifs, 3, rue Combemale, 59020 Lille cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.01.006DOI Listing
February 2019

[Epithelioid hemangioendothelioma].

Bull Cancer 2019 Jan 4;106(1):73-83. Epub 2018 Dec 4.

Centre Oscar Lambret, département d'oncologie médicale, 3, rue Frédéric Combemale, 59000 Lille, France; Hôpital Claude Huriez, service d'oncologie médicale, rue Michel Polonowski, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.11.004DOI Listing
January 2019

[Some important breakthroughs in oncology and hematology in 2018: A selection by the editorial board of Bulletin du Cancer].

Bull Cancer 2019 Jan 3;106(1):12-23. Epub 2019 Jan 3.

AP-HP, hôpitaux universitaires Paris Centre, hôpital Cochin, unité d'oncologie thoracique, service de pneumologie, 75014 Paris, France; Paris Descartes Université, centre de recherche des Cordeliers, équipe « cancer, immune control and escape », Inserm UMRS1138, 75006 Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183040
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.12.005DOI Listing
January 2019

[Prostate cancer screening: Reasons of controversy].

Bull Cancer 2018 Dec 17;105(12):1111-1118. Epub 2018 Nov 17.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France; CHRU de Lille, hôpital Claude-Huriez, service universitaire d'oncologie médicale, rue Michel-Polonowski, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.09.007DOI Listing
December 2018

[What role for the direct oral anticoagulants in oncology?]

Bull Cancer 2018 Jul - Aug;105(7-8):631-633. Epub 2018 Jun 28.

Université Lille-Nord de France, faculté de médecine, place de Verdun, 59000 Lille, France; Département de cancérologie générale, centre Oscar-Lambret, 3, rue Combemale, 59020 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.05.015DOI Listing
November 2018

[Dermatofibrosarcoma: Management].

Bull Cancer 2018 Nov 5;105(11):1094-1101. Epub 2018 Oct 5.

Centre Oscar Lambret, département de cancérologie générale, 3, rue F. Combemale, 59020 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.08.008DOI Listing
November 2018

[Adjuvant chemotherapy for upper tract urothelial cancer: Level of evidence IA].

Bull Cancer 2018 Oct 17;105(10):853-854. Epub 2018 Sep 17.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France; Hôpital Claude-Huriez, service universitaire d'oncologie médicale, rue Michel-Polonowski, 59037 Lille cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183023
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.07.017DOI Listing
October 2018

Reappraisal of eligibility criteria in cancer clinical trials.

Curr Opin Oncol 2018 09;30(5):352-357

Clinical Research and Innovation Department, Centre Oscar Lambret.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000470DOI Listing
September 2018

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma.

Eur J Cancer 2018 08 11;99:28-36. Epub 2018 Jun 11.

Department of Clinical Research and Innovation, Centre Oscar Lambret, 3 rue Combemale, 59000 Lille, France; Paris-Saclay University, Univ. Paris-Sud, CESP, INSERM, Gustave Roussy, 94805 Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.05.008DOI Listing
August 2018

[2017 ASCO: Complete androgen blockade strikes back].

Authors:
Nicolas Penel

Bull Cancer 2017 Jul - Aug;104(7-8):599-601. Epub 2017 Jul 5.

Département de cancérologie générale, centre Oscar-Lambret, 3, rue F.-Combemale, 59020 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.06.001DOI Listing
June 2018

[Requirement of DPD deficiency screening before prescription of fluoropyrimidines].

Authors:
Nicolas Penel

Bull Cancer 2018 04;105(4):331-332

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Frédéric-Combemale, 59000 Lille, France; Service d'oncologie médicale, hôpital Claude Huriez, CHRU de Lille, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2018.03.001DOI Listing
April 2018

Efficacy and safety of Sm-EDTMP as treatment of painful bone metastasis: a large single-center study.

Support Care Cancer 2018 Mar 17;26(3):751-758. Epub 2017 Sep 17.

Medical Oncology Department, Oscar Lambret Center, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-017-3885-3DOI Listing
March 2018

[Autoimmune hypophysitis associated with new anti-cancer immunotherapies].

Bull Cancer 2018 Mar 21;105(3):275-280. Epub 2018 Feb 21.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue F.-Combemale, 59020 Lille, France; CHRU de Lille, hôpital Claude-Huriez, service d'oncologie médicale, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.033DOI Listing
March 2018

Meta-analyses evaluating surrogate endpoints for overall survival in cancer randomized trials: A critical review.

Crit Rev Oncol Hematol 2018 Mar 23;123:21-41. Epub 2017 Nov 23.

Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Center, 229 Cours de l'Argonne, 33000 Bordeaux, France; INSERM CIC-EC 14.01 (Clinical Epidemiology), Bordeaux, France; INSERM, ISPED, Centre INSERM U1219 Bordeaux Population Health Center, Epicene Team, 146 Rue Léo Saignat, 33076 Bordeaux, France; University of Bordeaux, ISPED, Centre INSERM U1219 Bordeaux Population Health, Epicene Team, 146 Rue Léo Saignat, 33076 Bordeaux, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.11.014DOI Listing
March 2018

A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma.

Anticancer Drugs 2017 11;28(10):1157-1165

aDepartment of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy bSarcoma Unit, Medical Oncology, Royal Marsden Hospital, London, UK cLocomotive Apparatus Tumor Unit, Orthopedic Service, Coimbra University Medical Center, Coimbra, Portugal dSarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Germany eMedical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain fMedical Oncology, L'Institut Roi Albert II, Bruxelles, Belgium gClinical Division of Oncology, Medical University Vienna - General Hospital, Austria hCentre Oscar Lambret, General Oncology, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000560DOI Listing
November 2017

[Prostate cancer and DNA repair genes].

Authors:
Nicolas Penel

Bull Cancer 2017 Nov 9;104(11):958-961. Epub 2017 Oct 9.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue F.-Combemale, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.07.005DOI Listing
November 2017

How to emerge from the conservatism in clinical research methodology?

Curr Opin Oncol 2017 Sep;29(5):400-404

aMedical Oncology Department, Oscar Lambret Center, Lille, France bMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000399DOI Listing
September 2017

[Tyrosine kinase inhibitor as adjuvant treatment of renal cell carcinoma: 1 versus 3].

Authors:
Nicolas Penel

Bull Cancer 2017 Sep 29;104(9):705-706. Epub 2017 Jul 29.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue F.-Combemale, 59020 Lille cedex, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551173019
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2017.06.015DOI Listing
September 2017

Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism.

Case Rep Oncol Med 2017 26;2017:2683478. Epub 2017 Sep 26.

Medical Oncology Department, Oscar Lambret Cancer Centre, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/2683478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634569PMC
September 2017

Adult desmoid tumors: biology, management and ongoing trials.

Curr Opin Oncol 2017 Jul;29(4):268-274

aDepartment of Medical Oncology, Centre Oscar Lambret, Lille bDepartment of Biopathology, Institut Bergonié, Comprehensive Cancer Centre, Institut National de la Santé et de la Recherche Medicale (INSERM) U916, Bordeaux cDivision of Adult Oncology, Department of Medicine, Aix-Marseille Université, INSERM U910 and Timone Hospital, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470853PMC
July 2017

First-line management of metastatic castrate-resistant prostate cancer patients: Audit of real-life practices.

Bull Cancer 2017 Jun 5;104(6):552-558. Epub 2017 Apr 5.

Centre Oscar-Lambret, medical oncology department, 3, rue F.-Combemale, 59020 Lille, France; SIRIC ONCOLille Consortium, Clinical Research and Methodology Platform, 59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.02.002DOI Listing
June 2017

[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients].

Bull Cancer 2017 Mar 13;104(3):208-212. Epub 2016 Dec 13.

Centre Oscar-Lambret, département d'oncologie médicale, 3, rue Combemale, 59020 Lille cedex, France; CHRU de Lille, SIRIC OncoLille, 2, avenue Oscar-Lambret, 59037 Lille cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.11.007DOI Listing
March 2017

[β-catenin and desmoid tumors: The ideal biomarker?]

Authors:
Nicolas Penel

Bull Cancer 2017 Mar 20;104(3):205-207. Epub 2016 Dec 20.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue F-Combemale, 59020 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.11.019DOI Listing
March 2017

[Carcinoma of unknown primary site: From necropsy to epigenetic analysis].

Authors:
Nicolas Penel

Bull Cancer 2017 Feb 29;104(2):112-113. Epub 2016 Nov 29.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue F-Combemale, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.10.022DOI Listing
February 2017

[Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].

Bull Cancer 2017 Jan 19;104(1):6-19. Epub 2016 Dec 19.

CHU de Clermont-Ferrand, service de thérapie cellulaire et d'hématologie clinique adulte, 1, place Lucie-Aubrac, 63003 Clermont-Ferrand cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.11.009DOI Listing
January 2017

[Usefulness of social and educational approach in adolescents and young adults with cancer: The Lille team's experience].

Bull Cancer 2016 Dec 22;103(12):1011-1018. Epub 2016 Nov 22.

Centre de lutte contre le cancer Oscar-Lambret, unité d'onco-pédiatrie, 3, rue Frédéric-Combemale, 59000 Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.10.019DOI Listing
December 2016

Crossed views of burden and emotional distress of cancer patients and family caregivers during palliative care.

Psychooncology 2016 11 3;25(11):1278-1285. Epub 2015 Dec 3.

UDL3, SCALAB UMR CNRS 9193, Université de Lille, Villeneuve d'Ascq, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.4056DOI Listing
November 2016

PRognostic factor of Early Death In phase II Trials or the end of 'sufficient life expectancy' as an inclusion criterion? (PREDIT model).

BMC Cancer 2016 10 4;16(1):768. Epub 2016 Oct 4.

Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre Bordeaux, 229 cours de l'Argonne, 33076, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-016-2819-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050995PMC
October 2016

[Anti-PLD1 and anti-PD1 in advanced urothelial cancers: promises from early phase trials].

Authors:
Nicolas Penel

Bull Cancer 2016 Oct 4;103(10):811-812. Epub 2016 Oct 4.

Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.08.005DOI Listing
October 2016

Inappropriate dose of multitargeted tyrosine kinase inhibitors: the original sin.

Curr Opin Oncol 2016 09;28(5):437-40

Department of Medical Oncology, Centre Oscar Lambret, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000319DOI Listing
September 2016

[Splicing variant of androgen receptors (AR-V7): New paradigms].

Authors:
Nicolas Penel

Bull Cancer 2016 Sep 31;103(9):711-3. Epub 2016 Aug 31.

Centre Oscar-Lambret, Department of Medical Oncology, 3, rue Frédéric-Combemale, 59020, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.07.005DOI Listing
September 2016

[ASCO 2016: Confirmation of respective roles of docetaxel and cabazitaxel in prostate cancer patients].

Authors:
Nicolas Penel

Bull Cancer 2016 Sep 3;103(9):714-6. Epub 2016 Sep 3.

Centre Oscar-Lambret, Department of Medical Oncology, 3, rue Frédéric-Combemale, 59020 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.07.006DOI Listing
September 2016

Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patients.

Crit Rev Oncol Hematol 2016 Aug 7;104:108-14. Epub 2016 Jun 7.

Lille Nord de France University, Medical School (Research Unit EA 2694), Lille, France; SIRIC OncoLille Consortium, Lille, France; Clinical Research Unit, Oscar Lambret Cancer Centre, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2016.05.017DOI Listing
August 2016

[Phase 1 of clinical trial: The issue of dose-escalating].

Authors:
Nicolas Penel

Bull Cancer 2016 Jun;103(6):511-2

SIRIC OncoLille Consortium, Clinical Research and Methodology Platform, 59037 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2016.05.001DOI Listing
June 2016

Reply to B. Biswas and D. Dabkara.

J Clin Oncol 2016 Mar 28;34(7):764-5. Epub 2015 Dec 28.

Centre Leon Berard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4426DOI Listing
March 2016

Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials.

Crit Rev Oncol Hematol 2016 Feb 3;98:73-80. Epub 2015 Nov 3.

Medical Oncology Department, Centre Oscar Lambret, Lille, France; Methodological Platform of the SIRIC OncoLille Consortium, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.10.020DOI Listing
February 2016

[2015 through the eyes of the Bulletin of Cancer editorial board].

Bull Cancer 2016 Jan 15;103(1):3-17. Epub 2016 Jan 15.

Hôpitaux de Chartres, service oncologie hématologie, , site Louis-Pasteur, 28630 Chartres-Le-Coudray, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.11.006DOI Listing
January 2016

[Soft tissue sarcomas: Questions about reported clinical benefit].

Bull Cancer 2015 Oct 15;102(10):804-5. Epub 2015 Sep 15.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.06.005DOI Listing
October 2015

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.

J Clin Oncol 2015 Sep 27;33(25):2797-802. Epub 2015 Jul 27.

Isabelle L. Ray-Coquard, Philippe A. Cassier, and Jean-Yves Blay, Centre Léon Bérard and Claude Bernard University, Lyon; Julien Domont, Olivier Mir, and Axel Le Cesne, Gustave Roussy, Villejuif; Emmanuelle Tresch-Bruneel and Stéphanie Clisant, Centre Oscar Lambret; Nicolas Penel, Centre Oscar Lambret and Lille-Nord-de-France Medical School, Lille; Emmanuelle Bompas, Centre René Gauducheau, Nantes; Sophie Piperno-Neumann, Institut Curie, Paris; Antoine Italiano, Institut Bergonié, Bordeaux; Christine Chevreau, Institut Claudius Regaud, Toulouse; Didier Cupissol, Institut de Cancérologie de Montpellier, Val d'Aurelle, Montpellier; François Bertucci, Institut Paoli Calmette, Marseille; Jacques-Olivier Bay, Centre Jean Perrin, Clermont-Ferrand; Olivier Collard, Institut de Cancérologie de la Loire Lucien Neuwirth, Saint Priest en Jarez; Esma Saada-Bouzid, Centre Antoine Lacassagne, Nice; Nicolas Isambert, Centre Georges-François Leclerc, Dijon; and Corinne Delcambre, Centre François Baclesse, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.60.8505DOI Listing
September 2015

[Docetaxel and prostate cancer: Early but not too early].

Bull Cancer 2015 Sep 30;102(9):710-2. Epub 2015 Jul 30.

Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.06.006DOI Listing
September 2015

Selection of ultimately ill cancer patients able to fulfill a questionnaire: Identification of inherent biases.

Bull Cancer 2015 Sep 30;102(9):730-6. Epub 2015 Jul 30.

University Lille 3, URECA EA 1059 (Research Unit: Cognitive and Affective Sciences), UFR de psychologie, rue du Barreau, BP 60149, 59653 Villeneuve d'Ascq cedex, France; University Lille 2, EA 264 (Resarch Unit: Epidemiology and Care Quality) and SIRIC ONCoLille, Platform 4, place de Verdun, 59045 Lille cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.06.002DOI Listing
September 2015

Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.

Crit Rev Oncol Hematol 2015 Jul 30;95(1):125-31. Epub 2015 Jan 30.

Medical Oncology Department, Centre Oscar Lambret, Lille, France; Research Unit (EA2694), Medical School University, Lille-Nord de France University, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.01.010DOI Listing
July 2015

Metabolic disorders associated with the use of targeted cancer therapies.

Curr Opin Oncol 2015 May;27(3):258-66

aDepartment of General Oncology, Center Oscar Lambret, Lille, France bMedical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000176DOI Listing
May 2015

Pain burden in desmoid tumor patients: a survey of the French Advocacy Group SOS Desmoid.

Bull Cancer 2015 Mar 3;102(3):213-6. Epub 2015 Mar 3.

SOS Desmoïde, 45, rue René-La-Combe, 49100 Angers, France; Centre Oscar Lambret, General Oncology Department, 59020 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.02.001DOI Listing
March 2015

Comparison of response evaluation criteria in solid tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: a retrospective analysis.

Eur J Cancer 2015 Jan 9;51(2):202-9. Epub 2014 Dec 9.

Medical Oncology Department, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille cedex, France; Clinical Resarch and Methodological Platform, SIRIC OncoLille, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.11.008DOI Listing
January 2015

Mechanisms of resistance to imatinib mesylate in KIT-positive metastatic uveal melanoma.

Clin Exp Metastasis 2014 Jun 21;31(5):553-64. Epub 2014 Mar 21.

CNRS, UMR 6301 ISTCT, CERVOxy. GIP CYCERON, 14074, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-014-9649-2DOI Listing
June 2014

What is an active regimen in carcinoma of unknown primary sites? Analysis of correlation between activity endpoints reported in phase II trials. Correlation of activity endpoints in phase II trials.

Bull Cancer 2014 Apr;101(4):E19-24

Lille Nord-de-France University, Unit Research (EA 2694) Medical School, 1, place de verdun, 59000 Lille, France, Centre Oscar-Lambret, Methodology and Biostatistics Unit, 3, rue Frédéric-Combemale, 59020 Lille cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1934DOI Listing
April 2014

Tumor calcification: a new response pattern of myxoid liposarcoma to trabectedin.

Case Rep Oncol 2014 Jan 26;7(1):204-9. Epub 2014 Mar 26.

Department of Medical Oncology, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000360575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3999575PMC
January 2014

Nomogram to predict treatment outcome of fluoropyrimidine/platinum-based chemotherapy in metastatic esophageal squamous cell carcinoma.

Cancer Res Treat 2013 Dec 31;45(4):285-94. Epub 2013 Dec 31.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2013.45.4.285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893326PMC
December 2013